Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,206
  • Shares Outstanding, K 52,203
  • Annual Sales, $ 1,049 M
  • Annual Income, $ -760,500 K
  • 60-Month Beta 1.22
  • Price/Sales 0.12
  • Price/Cash Flow 2.89
  • Price/Book 0.20
Trade EBS with:

Options Overview Details

View History
  • Implied Volatility 104.60% ( -1.30%)
  • Historical Volatility 195.24%
  • IV Percentile 53%
  • IV Rank 14.96%
  • IV High 505.77% on 02/07/24
  • IV Low 34.00% on 10/11/23
  • Put/Call Vol Ratio 2.93
  • Today's Volume 334
  • Volume Avg (30-Day) 873
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 10,783
  • Open Int (30-Day) 23,924

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -3.65
  • Number of Estimates 1
  • High Estimate -3.65
  • Low Estimate -3.65
  • Prior Year -3.17
  • Growth Rate Est. (year over year) -15.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.12 +20.99%
on 03/14/24
3.72 -31.14%
on 03/05/24
-0.63 (-19.84%)
since 02/28/24
3-Month
1.42 +80.63%
on 02/06/24
3.72 -31.14%
on 03/05/24
+0.10 (+3.85%)
since 12/28/23
52-Week
1.42 +80.63%
on 02/06/24
13.67 -81.24%
on 04/11/23
-6.33 (-71.18%)
since 03/28/23

Most Recent Stories

More News
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript

EBS earnings call for the period ending December 31, 2023.

EBS : 2.55 (-1.54%)
Emergent Biosolutions: Q4 Earnings Snapshot

Emergent Biosolutions: Q4 Earnings Snapshot

EBS : 2.55 (-1.54%)
Emergent Biosolutions: Q3 Earnings Snapshot

Emergent Biosolutions: Q3 Earnings Snapshot

EBS : 2.55 (-1.54%)
Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript

EBS earnings call for the period ending September 30, 2023.

EBS : 2.55 (-1.54%)
Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic

/PRNewswire/ -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced it is teaming up with football icon, Emmitt Smith, to break down the stigma around...

EBS : 2.55 (-1.54%)
Why Emergent BioSolutions Stock Is Tumbling Today

The healthcare stock will soon be booted from an index tracked by several ETFs.

EBS : 2.55 (-1.54%)
Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600

/PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) will replace Advance Auto Parts Inc. (NYSE: AAP) in the S&P 500, and Advance Auto Parts will replace Emergent...

SPGI : 425.93 (+0.74%)
KVUE : 21.48 (+0.14%)
AAP : 85.30 (-0.02%)
EBS : 2.55 (-1.54%)
JNJ : 158.45 (+0.31%)
Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript

EBS earnings call for the period ending June 30, 2023.

EBS : 2.55 (-1.54%)
Emergent Biosolutions: Q2 Earnings Snapshot

Emergent Biosolutions: Q2 Earnings Snapshot

EBS : 2.55 (-1.54%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Emergent BioSolutions Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

EBS : 2.55 (-1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside...

See More

Key Turning Points

3rd Resistance Point 2.84
2nd Resistance Point 2.74
1st Resistance Point 2.66
Last Price 2.55
1st Support Level 2.49
2nd Support Level 2.39
3rd Support Level 2.31

See More

52-Week High 13.67
Fibonacci 61.8% 8.99
Fibonacci 50% 7.55
Fibonacci 38.2% 6.10
Last Price 2.55
52-Week Low 1.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar